New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...
Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...
Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
Experts discuss the integration of GLP-1 receptor agonists in treating neuroendocrine tumors, highlighting safety concerns ...
The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback